We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HXL:NYSEHexcel Corporation Analysis

Data as of 2026-04-09 - not real-time

$83.31

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Hexcel (HXL) trades at a steep premium, with a trailing P/E of 60.8 versus an industry average of 30.7, and a discounted cash‑flow fair value of only $12.2 compared to the current price of $83.3. The stock shows a modest technical upside: MACD is bullish, the 20‑day SMA (80.63) sits just below the market price, and the next resistance level is around $86.2, while support lies near $76.3. However, volatility is elevated at 37.6%**30‑day** and volume is trending down, indicating a neutral market stance. Fundamentals reveal modest revenue growth (3.7%), thin margins (gross 22.9%, profit 5.8%) and a high debt‑to‑equity ratio of 81.5%, though free cash flow remains positive and the dividend payout ratio is under 50%, supporting dividend sustainability. Analyst consensus is a “buy” with a mean target of $88.2, implying only a 5.9%**upside** despite the lofty valuation metrics. The company benefits from strong aerospace and defense demand, but the combination of high valuation, debt load, and price volatility tempers enthusiasm.
Given these dynamics, short‑term investors may capture limited upside near the next resistance, while medium‑term holders can benefit from the sector’s growth trajectory if the valuation compresses. Long‑term investors should remain cautious, as the current price appears disconnected from intrinsic estimates and the firm’s modest profitability may not justify the premium without a clear earnings acceleration.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and price near 20‑day SMA
  • Limited upside to near‑term resistance at $86.2
  • Sustained dividend with payout ratio below 50%

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong aerospace and defense demand driving revenue growth
  • Analyst target median of $90 indicating modest upside
  • Forward P/E of 27 suggesting earnings improvement

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Current price far exceeds DCF fair value ($12.2)
  • High debt‑to‑equity ratio and thin profit margins
  • Potential valuation compression if earnings accelerate

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin5.78%
P/E Ratio60.8
ROE7.87%
ROA4.70%
Debt/Equity81.45
P/B Ratio5.0
Op. Cash Flow$230.5M
Free Cash Flow$118.4M
Industry P/E30.7

Technical Analysis

TrendNeutral
RSI52.4
Support$76.27
Resistance$86.24
MA 20$80.63
MA 50$84.88
MA 200$71.67
MACDBullish
VolumeDecreasing
Fear & Greed Index83.45

Valuation

Fair Value$12.17
Target Price$88.20
Upside/Downside5.87%
GradeOvervalued
TypeBlend
Dividend Yield0.83%

Risk Assessment

Beta0.92
Volatility37.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.